Connection

Jiangning Liu to Pneumonia, Viral

This is a "connection" page, showing publications Jiangning Liu has written about Pneumonia, Viral.
Connection Strength

0.064
  1. Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy. Cell. 2020 11 12; 183(4):1013-1023.e13.
    View in: PubMed
    Score: 0.007
  2. Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in rhesus macaques. Nat Commun. 2020 09 02; 11(1):4400.
    View in: PubMed
    Score: 0.007
  3. Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 via Close Contact and Respiratory Droplets Among Human Angiotensin-Converting Enzyme 2 Mice. J Infect Dis. 2020 07 23; 222(4):551-555.
    View in: PubMed
    Score: 0.007
  4. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques. Science. 2020 08 14; 369(6505):818-823.
    View in: PubMed
    Score: 0.007
  5. Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2. Cell. 2020 08 06; 182(3):713-721.e9.
    View in: PubMed
    Score: 0.007
  6. Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells. Cell. 2020 07 09; 182(1):73-84.e16.
    View in: PubMed
    Score: 0.007
  7. Therapeutic efficacy of Pudilan Xiaoyan Oral Liquid (PDL) for COVID-19 in vitro and in vivo. Signal Transduct Target Ther. 2020 05 08; 5(1):66.
    View in: PubMed
    Score: 0.007
  8. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature. 2020 07; 583(7818):830-833.
    View in: PubMed
    Score: 0.007
  9. Development of an inactivated vaccine candidate for SARS-CoV-2. Science. 2020 07 03; 369(6499):77-81.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.